Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Nano-X Imaging Ltd. (NNOX)

0.3020 -0.0281 (-8.51%)
At close: 4:00:01 PM EST
0.3082 +0.0062 (+2.05%)
After hours: 5:27:59 PM EST
Trade NNOX on Coinbase
Chart Range Bar
Loading chart for NNOX
  • Previous Close 0.3301
  • Open 0.3301
  • Bid 1.0200 x 200
  • Ask 1.2900 x 200
  • Day's Range 0.3020 - 0.3420
  • 52 Week Range 0.2790 - 4.7050
  • Volume 787,795
  • Avg. Volume 1,138,290
  • Market Cap (intraday) 23.782M
  • Beta (5Y Monthly) 1.36
  • PE Ratio (TTM) --
  • EPS (TTM) -1.7200
  • Earnings Date (est.) Nov 19, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 4.13
  • Zacks Rating Neutral

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligence–based solution; AI-Based Body Composition Measurement, an artificial intelligence–based body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.

www.nanox.vision

197

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

NNOX
89.21%
S&P 500 (^GSPC)
10.17%

1-Year Return

NNOX
91.68%
S&P 500 (^GSPC)
10.25%

3-Year Return

NNOX
94.78%
S&P 500 (^GSPC)
74.66%

5-Year Return

NNOX
98.73%
S&P 500 (^GSPC)
62.86%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 4.31M
Earnings -14.27M
Profit Margin -330.90%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

-30M
-20M
-10M
0
-800.0%
-600.0%
-400.0%

Analyst Insights

View More

Analyst Price Targets

3.00
4.13 Average
0.3020 Current
5.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/17/2026
Analyst Cantor Fitzgerald
Rating Action Reiterates
Rating Overweight
Price Action Maintains
Price Target 5 -> 5

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -27.86%

  • Return on Equity (ttm)

    -98.98%

  • Revenue (ttm)

    15.63M

  • Net Income Avi to Common (ttm)

    -116.81M

  • Diluted EPS (ttm)

    -1.7200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    31.02M

  • Total Debt/Equity (mrq)

    10.66%

  • Levered Free Cash Flow (ttm)

    -30.8M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: